https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure

"In this trial, 3,441 people received Evusheld and 1,731 received a placebo. In the primary analysis, Evusheld recipients saw a 77% reduced risk of developing COVID-19 "

This could mean that 10 in each group got COVID...and 5,100 didn't. Yet all should take continuous drugs and side effects be damned!
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure "In this trial, 3,441 people received Evusheld and 1,731 received a placebo. In the primary analysis, Evusheld recipients saw a 77% reduced risk of developing COVID-19 " This could mean that 10 in each group got COVID...and 5,100 didn't. Yet all should take continuous drugs and side effects be damned!
WWW.FDA.GOV
Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in Certain Individuals
The FDA authorized new long-acting monoclonal antibodies for the pre-exposure prevention of COVID-19 in certain adults and pediatric individuals.
Like
1
0 Comments 0 Shares 117 Views